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Abstract
Chronic obstructive pulmonary disease (COPD) is linked to both cigarette smoking and genetic 
determinants. We have previously identified iron-responsive element binding protein 2 (IRP2) as 
an important COPD susceptibility gene, with IRP2 protein increased in the lungs of individuals 
with COPD. Here we demonstrate that mice deficient in Irp2 were protected from cigarette smoke 
(CS)-induced experimental COPD. By integrating RIP-Seq, RNA-Seq, gene expression and 
functional enrichment clustering analysis, we identified IRP2 as a regulator of mitochondrial 
function in the lung. IRP2 increased mitochondrial iron loading and cytochrome c oxidase (COX), 
which led to mitochondrial dysfunction and subsequent experimental COPD. Frataxin-deficient 
mice with higher mitochondrial iron loading had impaired airway mucociliary clearance (MCC) 
and higher pulmonary inflammation at baseline, whereas synthesis of cytochrome c oxidase 
(Sco2)-deficient mice with reduced COX were protected from CS-induced pulmonary 
inflammation and impairment of MCC. Mice treated with a mitochondrial iron chelator or mice 
fed a low-iron diet were protected from CS-induced COPD. Mitochondrial iron chelation also 
alleviated CS-impairment of MCC, CS-induced pulmonary inflammation and CS-associated lung 
injury in mice with established COPD, suggesting a critical functional role and potential 
therapeutic intervention for the mitochondrial-iron axis in COPD.
Keywords
COPD; Mitochondria; Iron; IRP2; Lung
Chronic obstructive pulmonary disease (COPD) presents as a complex debilitating lung 
disease that encompasses a variety of clinical and pathologic phenotypes ranging from 
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airway inflammation (chronic bronchitis) to destruction of lung tissue (emphysema) and 
remodeling of the small airways1,2. The pathogenesis of COPD remains poorly understood, 
but involves aberrant inflammatory and dysregulated cellular responses of the lung to 
cigarette smoke (CS) exposure1.
CS exposure remains the greatest environmental risk factor for COPD; however, multiple 
studies have suggested that genetic factors influence COPD susceptibility3. We previously 
identified iron-responsive element binding protein 2 (IRP2, also known as IREB2) as a 
leading candidate COPD susceptibility gene4–6 based on genome-wide association studies 
(GWASs), and we demonstrated that IRP2 protein is increased in the lungs of COPD 
subjects4. IRP2 is located within a cluster of genes on chromosome 15q25, which includes 
several components of the nicotinic acetylcholine receptor. In addition to COPD, 15q25 has 
been associated with lung cancer, peripheral arterial disease and nicotine addiction in 
GWASs7–10.
The iron regulatory proteins (IRPs) IRP1 and IRP2 regulate cellular iron homeostasis, with 
IRP2 serving as the major regulatory protein in mammalian cells11. IRPs have important 
physiological roles in the duodenum, spinal cord and central nervous system, and in the 
pathogenesis of pulmonary hypertension and neurodegenerative diseases12–15. In the setting 
of iron depletion, IRPs decrease iron storage and increase iron uptake by the binding to iron 
response elements (IREs) located in the mRNA of genes involved iron homeostasis, 
resulting in translational repression or stabilization of the transcripts12,15. The critical 
physiologic function of IRP2 in the lung, in particular the mRNA transcripts targeted by 
IRP2 are not well known, nor is it clear whether IRP2 has a role in the response of the lung 
to CS exposure or in the pathogenesis of CS-induced COPD.
In this study we sought to delineate the function of the COPD susceptibility gene IRP2 in 
the pathogenesis of CS-induced COPD by integrating human COPD expression data with 
experimental mouse models of COPD. Our studies are the first to characterize a functional 
role for IRP2 in the lung wherein IRP2 promotes mitochondrial dysfunction in experimental 
COPD by regulating mitochondrial iron loading and cytochrome c oxidase. Importantly, we 
also show that mitochondrial iron chelation using the siderophore deferiprone alleviates 
established disease in a model of CS-induced pulmonary inflammation and injury 
(experimental COPD), highlighting a potential novel therapeutic approach for COPD.
RESULTS
IRP2 deficient mice resist experimental COPD
To characterize the functional role of IRP2 in the pathogenesis of COPD, we used two well-
established experimental models of CS-induced COPD, namely CS-induced emphysema (4–
6 months exposure)16,17 and CS-induced impairment of mucociliary clearance (MCC) (1 
month exposure)17,18. MCC, characterized by the upward movement of mucus by ciliary 
motion, can be impaired by airway cell dysfunction19, or infiltration of immune cells into 
the lung20. Impaired MCC leads to excessive airway mucus, recurrent pulmonary infection 
and chronic bronchitis1.
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Consistent with our observations in lungs from human COPD subjects4, we observed higher 
Irp2 expression (with no change in Irp1 expression) and activity in the lungs of wild-type 
(WT) mice exposed to CS for 1–6 months when compared to room air (RA)-exposed 
controls (Fig. 1a–c). Irp2 expression localized in lung epithelial cells, including type I 
alveolar (podoplanin positive), type II alveolar (SPC positive), secretory airway (uteroglobin 
positive) and ciliated airway (acetylated alpha tubulin positive) cells (Fig. 1d and 
Supplementary Fig. 1a, b). Irp2 expression also appeared to localize to the walls of 
intermediate size vessels with negligible staining in basal (cytokeratin 5 positive) epithelial 
cells (Supplementary Fig. 1b. Irp2 expression was higher in type I, type II, secretory and 
ciliated epithelial cells as well as in infiltrating alveolar macrophages in response to CS (6 
months), when compared to RA controls (Fig. 1d and Supplementary Fig. 1a, b). We also 
observed higher Irp2 expression upon aqueous CSE (cigarette smoke extract) treatment (an 
in vitro model of CS exposure), in primary human bronchial airway epithelial cells and in 
the human bronchial airway epithelial cell line Beas2B, compared to RA-exposed controls 
(Supplementary Fig. 1c, d).
Overexpression of Irp2 has been associated with embryonic lethality in mice21; we therefore 
used a loss of function approach to study the function of Irp2 in experimental COPD. WT 
mice exposed to CS for 4–6 months had higher mean chord lengths, air space diameters 
(Fig. 1d and Supplementary Fig. 2a) and greater thickness of the small airways (all 
established indices of experimental COPD2,17), when compared to RA-exposed WT mice 
(Fig. 1e). Irp2−/− mice resisted CS-induced changes in mean chord length and air space 
diameter and were protected from small airway remodeling (Fig. 1e, f and Supplementary 
Fig. 2a). Irp2−/− mice were also protected from CS-induced injury markers, previously 
shown to be associated with emphysema, including cleaved caspase-3 (increased 
apoptosis)22, matrix metalloproteinase 9 (MMP9)23 expression and the autophagy markers 
LC3B17 and Atg7 (Fig. 1g and Supplementary Fig. 2b, b). Irp1 expression did not change in 
RA- or CS-exposed Irp2−/− mice (Supplementary Fig. 2d).
We have recently developed an experimental model of CS-induced bronchitis by exposing 
mice acutely to CS (1 month) and measuring their mucociliary clearance17,18 (Fig. 1h). In 
this model, bronchoalveolar lavage fluid (BALF) from CS-exposed WT mice had greater 
leukocyte counts and had greater total BALF protein levels (an indicator of increased 
epithelial cell injury and permeability24) when compared to RA-exposed WT mice 
(Supplementary Fig. 2e, f). CS-exposed mice also had higher BALF interleukin (IL)-33 
protein concentrations (a pleiotropic cytokine predominantly expressed in lung tissue that 
induces airway inflammation in naive mice25) and higher BALF IL-6 protein concentrations 
(a cytokine associated with the severity of acute COPD exacerbations and decline in lung 
function26), when compared to RA-exposed WT mice (Fig. 1i). Using this model, the MCC 
of WT lungs exposed to CS was significantly lower compared with RA-exposed controls (P 
< 0.05) (Fig. 1h). Irp2−/− mice were protected from CS-impaired MCC and CS-exposed 
Irp2−/− mice exhibited less BALF IL-6 and IL-33 protein concentrations when compared to 
CS-exposed WT mice (Fig. 1h, i). Irp2 deficiency failed to protect against lung injury 
(greater BAL leukocytes, BALF protein and BAL IL-6 and IL-33 protein) and mortality in a 
hyperoxia-induced acute lung injury mouse model and in a cecal ligation and puncture-
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induced polymicrobial sepsis mouse model (Supplementary Fig. 3a–g), highlighting the 
specificity of the functional role of IRP2 in CS-induced lung injury associated with COPD.
Identification of novel target pathways of IRP2 in the lung
As described above, IRP2 conferred important functional impact in the pathogenesis of 
COPD in two experimental COPD models. We therefore sought to delineate the mechanism 
by which IRP2 promoted experimental COPD by first identifying the downstream targets of 
IRP2 in the lung. For unbiased identification of RNA targets of IRP2, we used the human 
airway epithelial cell line Beas2B stimulated with or without deferoxamine (DFO) (to 
stabilize IRP2 expression27), immunoprecipitated IRP2-RNA complexes and performed 
whole transcriptome sequencing (RIP-Seq) (Supplementary Fig. 4a–c). This analysis 
identified 1806 IRP2-related target genes, which included transcripts for known IRP2 
targets, including ferritin and transferrin receptor (TfR) (confirmed by qPCR) 
(Supplementary Fig. 4d–f), thus validating the model system.
To better understand the biological meaning behind the IRP2 target genes, functional 
enrichment clustering analysis (See Methods and Supplementary Fig. 4g) identified five core 
functional “communities” or pathways (depicted as word clouds), as demonstrated by the 
Circos plot in Fig. 2a. On this plot, the differential-expression of genes in lung tissue of 
individuals with COPD (Lung Genomics Research Consortium or LGRC) compared to 
controls (black ring) is also shown (Fig. 2a). We observed that many of the genes in each of 
the five communities had altered expression in COPD subjects and were known to be 
involved in the progression or pathogenesis of COPD (Supplementary Table 1).
To associate this human data to the heterogeneous in vivo environment of the lung in the 
absence of IRP2, we evaluated each of the five RIP-Seq communities for differential-
expression patterns using a microarray study of lungs from WT and Irp2−/− mice (Fig. 2b). 
This analysis identified one community, Community 2, as having the most significant 
differential expression between the Irp2−/− and WT mice (Fig. 2c) (P = 1.08×10−8). In 
Community 2, the main pathway (from Gene Ontology terms, see Fig. 3a and 
Supplementary Fig. 5) that emerged was related to mitochondrial function, with identified 
differentially expressed genes presented in Fig. 3a.
To assess the relationship between the differentially expressed mitochondrial genes in Fig. 
3a to IRP2 expression in human subject with COPD, we evaluated the expression pattern of 
these genes in individuals (COPD and controls) with high or low IRP2 expression, using two 
human COPD cohorts, namely the LGRC (gene expression in lung tissue) and ECLIPSE 
(Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points) (gene 
expression in blood) cohorts. A strong association between the differential-expression of 
mitochondrial genes and differences in IRP2 expression was observed, with an overall 
stronger association observed in COPD subjects (Fig. 3b, c and Supplementary Fig. 6).
Irp2−/− mice resist CS-induced mitochondrial dysfunction
Based on the functional pathways highlighted in the RIP-Seq and differential-expression 
analysis observed in mice and humans, we assessed the functional role of IRP2 in 
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mitochondrial responses to CS in experimental COPD. Lung epithelial cells from WT mice 
exposed to CS had abnormal mitochondrial morphology with evidence of cristae loss and 
mitochondrial swelling (Fig. 3d). Irp2−/− mice had higher abnormal mitochondrial 
morphology at baseline compared to WT controls and in response to CS; Irp2−/− mouse 
airway cells had fewer mitochondria with abnormal morphology (Fig. 3d). 
Immunohistochemical staining for cytosolic cytochrome c, a marker of mitochondrial 
damage28 demonstrated that CS-induced mitochondrial damage localized to alveolar and 
airway epithelial cells in WT mice. Irp2−/− mice, however, exhibited negligible staining for 
cytosolic cytochrome c in airway or alveolar epithelial cells after CS exposure (Fig. 3e and 
Supplementary Fig. 7).
Mitochondria isolated from whole lung homogenates of CS-exposed WT mice had lower 
membrane potential (ΔΨ), as indicated by JC1 uptake compared to RA-exposed controls 
(Fig. 3f). Mitochondria isolated from whole lung homogenates of Irp2−/− mice were 
protected from CS-induced decreases in ΔΨ (Fig. 3f). Similarly, primary lung epithelial cells 
isolated from Irp2−/− mice were resistant to CSE-induced mitochondrial depolarization 
compared to WT cells, as measured by TMRE staining (Fig. 3g). Human airway epithelial 
cells deficient in IRP2 (treated with siRNA for IRP2) were protected from CSE-induced cell 
death and from the production of CSE-induced mitochondrial reactive oxygen species 
(mtROS)17 (Supplementary Fig. 8a, b). Taken together, these data implicated IRP2 as a 
regulator of CS-induced mitochondrial dysfunction in experimental COPD.
Using a Seahorse XF96 apparatus, which provides information on mitochondrial function 
through real-time measurements of oxygen consumption rate (OCR), a marker of oxidative 
phosphorylation (OXPHOS), and extracellular acidification (ECAR), a surrogate of 
glycolysis, we determined the rates and reserve capacity of OXPHOS and glycolytic 
activity, in CSE-exposed WT and Irp2−/− primary lung epithelial cells (Fig. 3h). CSE-
exposed WT cells had lower OCR: ECAR ratios when compared to RA-exposed cells, 
indicative of cells shifting energy metabolism from OXPHOS to glycolysis. CSE-exposed 
Irp2−/− cells had the opposite response in OCR:ECAR ratio, characterized by greater 
OXPHOS relative to glycolysis, indicative of enhanced aerobic mitochondrial metabolism 
with less reliance on glycolysis (Fig. 3h). These results suggest that in lung epithelial cells, 
IRP2 regulated switching from aerobic (OXPHOS) to anaerobic metabolism, as an adaptive 
response to mitochondrial dysfunction (Fig. 3i).
IRP2 promotes CS-induced mitochondrial iron loading
Mitochondria are the main consumers of intracellular iron and a number of vital cellular 
processes rely on precise mitochondrial iron regulation29. Failure to control mitochondrial 
iron leads to mitochondrial iron loss or excessive mitochondrial iron overload, both of which 
can lead to mitochondrial dysfunction29. We wished to investigate whether the observed 
IRP2-mediated mitochondrial responses to CS (Fig. 3d–h) were related to IRP2-mediated 
alterations in mitochondrial iron pathways in the lung.
We first investigated whether CS regulated general iron metabolism in the lung. In body 
tissues, iron (Fe) is found either as non-heme free iron in the ferric (Fe3+) or ferrous (Fe2+) 
state or as heme iron (Fe2+ complexed with protoporphyrin IX)30. Consistent with greater 
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Irp2 expression in CS-exposed WT mice, WT mice had higher non-heme iron in inflated 
lung sections and in whole lung homogenates when compared to RA-exposed mice (Fig. 
4a). Whole lung homogenates of WT mice also had higher and lower expression of the Irp2-
target proteins TfR and ferritin respectively (Fig. 4b). Additionally, intracellular free iron 
was higher in human airway epithelial cells upon exposure to aqueous CSE when compared 
to RA-exposed (Supplementary Fig. 8a). These data suggested that in experimental models 
of COPD, CS increased iron deposition in the airways of mice. CS-exposed Irp2−/− mice 
had similar total non-heme iron levels in whole lung tissue, when compared to CS-exposed 
WT mice (Fig. 4c); however Perls’ stained CS-exposed Irp2−/− mouse lungs had less iron 
deposition than Perl’s stained CS-exposed WT mouse lungs (Supplementary Fig. 8b). 
Furthermore, intracellular free iron did not change in CSE-exposed human airway epithelial 
cells deficient in IRP2 (treated with shRNA targeted to IRP2) (Supplementary Fig. 8a).
Once inside the cell, free iron may be delivered to ferritin30, to iron-containing proteins, or 
may be imported into mitochondria for heme or iron-sulfur (Fe-S) cluster biosynthesis. Non-
heme and heme iron levels were higher in mitochondrial fractions of WT mouse lungs 
exposed to CS when compared to RA-exposed controls (Fig. 4c, d). Increased mitochondrial 
iron import is reliant on the use of the inner mitochondrial membrane iron transporter 
mitoferrin 231. Mitoferrin 2 levels were higher in CS-exposed mice when compared to RA-
exposed controls (Fig. 4e), suggesting increased import of iron into mitochondria. Another 
indicator of increased iron loading, loss of the mitochondrial Fe-S regulator frataxin32, was 
also associated with CS exposure in whole lung homogenates of WT mice as well as in 
human airway epithelial cells treated with CSE (Fig. 4f and Supplementary Fig. 8c). Ferritin 
expression was lower in CS-exposed lung tissues when compared to RA-exposed mice, but 
did not change the expression of cytosolic non-heme or heme iron or the cytosolic iron 
binding protein F-box and leucine-rich repeat protein 5 (FBXL5, also a negative regulator of 
IRP221) (Supplementary Fig. 8d–f). Additionally, CSE impaired mitochondria and cytosolic 
Fe-S cluster assembly in human airway epithelial cells (Supplementary Fig. 8g). Taken 
together, these data demonstrated that CS induced mitochondrial iron loading in 
experimental COPD.
Irp2−/− mice were protected from the effects of CS on ferritin and mitoferrin 2 expression 
when compared to CS-exposed WT mice (Fig. 4d, e and Supplementary Fig. 8d). Irp2−/− 
mice were also protected from CS-associated higher mitochondrial non-heme iron and 
mitochondrial heme iron levels (Fig. 4d), suggesting that IRP2 promoted CS-induced 
mitochondrial iron loading. We have previously shown that heme oxygenase 1 (HO-1), an 
enzyme that catalyzes the degradation of heme to produce iron was elevated in the CS-
exposed mouse lungs and may have a protective role in regulating CS-induced 
mitochondrial-mediated cell death33. Herein we show that Irp2−/− mice had higher baseline 
levels of HO-1, which did not change upon CS exposure compared to CS-exposed WT mice 
(Supplementary Fig. 8h), suggesting more baseline protection from mitochondrial-mediated 
cell death.
To assess whether abnormally increased mitochondrial iron overload was pathogenic in 
experimental COPD, we evaluated whether mice with higher mitochondrial iron loading 
(that is, mice with reduced frataxin expression32) had differential responses to CS in our CS-
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induced impairment of MCC (bronchitis model). We chose to use this acute 1-month 
exposure model to test our hypothesis, as we observed significant differences (P < 0.05) in 
CS-induced mitochondrial iron loading between the WT and Irp2−/− mice at this time-point 
(Fig. 4d). Here we found that mice deficient in frataxin (that is, mice with a heterozygous 
transgenic insertion (GAA230 expansion) of mutated frataxin (KI) and a heterozygous 
deletion of frataxin (KO) (Fxnki/ko)) had higher mitochondrial non-heme and heme iron 
levels and displayed significantly impaired baseline MCC function (P < 0.05), as well as 
higher baseline levels of whole lung IL-6 protein concentrations (Fig. 4g, h), when 
compared to WT mice. This data suggested that CS-induced mitochondrial iron loading 
might be pathogenic in experimental COPD (Fig. 4i).
IRP2 and CS increased lung COX activity and expression
To investigate the mechanism of IRP2-associated mitochondrial iron loading and CS-
induced mitochondrial dysfunction, we focused our attention to the mitochondrial genes 
identified in our RIP-Seq study and community-based gene expression analysis (Fig. 3a). 
The most significant differentially expressed gene (P < 0.01) in this analysis was 
cytochrome C oxidase (COX) assembly factor 3 (Coa3) with Irp2−/− mice having lower 
expression than WT mice (Fig. 3a and Fig. 5a). COA3 encodes coiled coil domain-
containing protein 56 (CCDC56), a mitochondrial protein that stabilizes COX subunit-I and 
promotes its assembly and activity34 (Fig. 5a). COX is the terminal electron acceptor of the 
mitochondrial electron transport chain responsible for the conversion of oxygen into water. 
A number of other subunits and factors important for COX assembly (Cox18, Cox8A) and 
mitochondrial OXPHOS including NADH dehydrogenase (Ubiquinone) 1 (Nduf) alpha 
subcomplex, 6 (Nduf66) and Nduf beta subcomplex, 9 (Nduf9) (Complex I), succinate 
dehydrogenase complex, subunit B, iron sulfur (Sdhb) (Complex II) and ubiquinol-
cytochrome C reductase hinge protein (Uqcrh) (Complex III) were also differentially 
expressed in Irp2−/− versus WT mice by this analysis, as well as other proteins important for 
mitochondrial integrity and apoptosis (Fig. 3a).
It has been proposed that COX acts as a key regulator of mitochondrial iron metabolism35. 
Specifically, COX-subunit I is regulated by heme and is the site of iron reduction and 
transport into mitochondria35, where it supplies iron for heme biosynthesis35. Consistent 
with higher Irp2 expression and with altered expression of COX-related mitochondrial genes 
in WT mice versus Irp2−/− mice (Fig. 3a and Fig. 5a), we show that COX expression is 
higher in COPD lung biopsies when compared to control subjects (Fig. 5a).
Using an antibody that detects each complex of the mitochondrial electron transport chain, 
we show that COX expression was higher in CS-exposed WT mice compared to CS-exposed 
Irp2−/− mice (Fig. 5b). Irp2−/− mouse lungs also exhibited less CS-induced reduction in the 
expression of Complexes I and II (Supplementary Fig. 9a). Expression of the lung specific 
isoform of COX (COX4I2), which renders lung COX two-fold more active, compared with 
COX in other tissues that lack COX4I236, was also higher in CS-exposed WT mice. Irp2−/− 
mice had lower COX4I2 expression when compared to WT mice, which did not change 
upon CS exposure (Supplementary Fig. 9b). Similarly, COX activity was higher in 
mitochondrial fractions isolated from WT mice exposed for 1 month and 4 months CS 
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compared to RA-exposed controls (Fig. 5c). COX activity was higher in mitochondria from 
CS-exposed WT mouse lungs but did not change in mitochondria from CS-exposed Irp2−/− 
mouse lungs (Fig. 5c). CSE-exposed WT lung epithelial cells had greater COX expression 
and activity compared to CSE-exposed airway epithelial cells from Irp2−/− mice (Fig. 5d).
To examine the function of COX in the response of the lung to CS, we used mice with 
impaired COX (activity and expression) in our CS-induced bronchitis model. COX is a 
multi-subunit complex whose assembly requires >20 ancillary factors including synthesis of 
cytochrome c oxidase (SCO2)37 (Fig. 5a). We have previously shown using serial analysis 
of gene expression (SAGE) that SCO2 is higher in the lungs of subjects with COPD when 
compared to healthy smokers and non-smokers38. Homozygous deletion of Sco2 is 
embryonic lethal in mice37; however, mice harboring a Sco2 knock-in (KI) mutation on one 
allele and a deletion of Sco2 on the other allele (KO) or mice harboring two KI mutations 
have COX assembly defects and impaired COX activity (with Sco2ki/ko mice having more 
severe COX deficiency than Sco2ki/ki mice37). We assessed the MCC of Sco2ki/ko and 
Sco2ki/ki mice exposed acutely to CS. WT mice had impaired MCC, higher BAL leukocyte 
counts and higher total BALF protein levels (Fig. 5e and Supplementary Fig. 9c, d). 
Conversely, Sco2ki/ko and Sco2ki/ki mice were protected from CS-induced loss of MCC 
(with Sco2ki/ko having greater protection than Sco2ki/ki mice) (Fig. 5e and Supplementary 
Fig. 9c). CS-exposed Sco2ki/ko mice exhibited lower BALF total protein, IL-6, and IL-33 
protein concentrations and lower BAL leukocyte counts than CS-exposed WT mice (Fig. 5e 
and Supplementary Fig. 9d) supporting the hypothesis that increased COX confers 
pathogenicity in experimental COPD.
To determine whether loss of COX resulted in higher mitochondrial iron in a similar manner 
to loss of Irp2, we measured total lung tissue non-heme iron levels, as well as cytosolic and 
mitochondrial iron (non-heme and heme) in WT and Sco2ki/ko mouse lungs exposed to RA 
or CS (1 month). Consistent with results obtained in WT mice, CS-exposed WT mice had 
higher total lung non-heme iron levels as well as higher mitochondrial non-heme and heme 
iron levels compared to RA-exposed WT mice (Fig. 5g–h). Similar to the Irp2−/− mice, 
Sco2ki/ko mice were protected from CS-associated changes in mitochondrial non-heme iron 
(Figs. 4d and 5h). No difference in mitochondrial heme levels or cytosolic non-heme and 
heme iron levels was observed in RA- or CS-exposed Sco2ki/ko mice, when compared to the 
WT mice (Fig. 5h and Supplementary Fig. 9e, f). These data suggested that Irp2 increased 
COX, which may be associated with altered mitochondrial non-heme iron in experimental 
COPD (Fig. 5i).
Targeting mitochondrial iron in experimental COPD
To test the hypothesis that Irp2 increased mitochondrial iron loading, which led to 
mitochondrial dysfunction in experimental COPD, we first assessed whether modulating 
iron in the diets of WT mice altered responses to CS in our CS-induced bronchitis model. 
Mice fed a low-iron diet had lower serum and lower lung non-heme iron levels, and were 
protected from CS-induced MCC impairment (with no effect on weight gain) when 
compared to mice fed a control iron diet (Fig. 6a, b and Supplementary Fig. 10a). Mice fed a 
high-iron diet had higher non-heme iron (serum and lung) levels when compared to mice fed 
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a control iron diet. Mice fed a high iron diet demonstrated impaired weight gain at baseline, 
but exhibited similar mucociliary responses to CS when compared to mice fed a control iron 
diet (Fig. 6a, b and Supplementary Fig. 10a).
We next examined whether alleviating excess mitochondrial iron would alter responses to 
CS in our CS-induced bronchitis model. Deferiprone (DFP or ferriprox®) is an iron chelator 
that specifically targets mitochondrial non-heme iron deposits and relocates them elsewhere 
to prevent mitochondrial iron loading39,40. Administration of DFP for the duration of CS-
exposure protected mice from CS-induced MCC impairment (Fig. 6c). The protection 
afforded from DFP treatment was similar to that obtained in the Irp2−/− mice. 
Administering DFP and Irp2 deficiency had synergistic effects; specifically DFP-treated 
Irp2−/− mice had better protection from CS-induced MCC impairment than DFP or Irp2−/− 
alone (Fig. 6c).
Finally, we evaluated whether mitochondrial iron chelation could alleviate established 
experimental COPD (pulmonary inflammation and injury) when administered as a 
therapeutic dosing strategy. WT mice with existing impaired MCC (developing after 4 
weeks of CS exposure) that were then treated with DFP during an additional 1.5 or 3 weeks 
of CS exposure had significantly improved mucociliary clearance (P < 0.05) when compared 
with mice exposed to CS for the same time period but without DFP (Fig. 6c). Similarly WT 
mice exposed to CS for 6 or 8 weeks and administered DFP after 4 weeks of CS exposure 
showed improved weight gain and had lower lung mitochondrial iron loading when 
compared with mice that were exposed to smoke for 6 or 8 weeks CS but not treated with 
DFP (Fig. 6d, e). WT mice with CS-induced pulmonary inflammation and injury (higher 
BAL leukocyte counts and total BALF protein, higher BALF IL-33 protein concentrations 
and higher whole lung tissue IL-6 protein concentration after 4 weeks of CS exposure) that 
were then treated with DFP during an additional 2 or 4 weeks of CS also showed significant 
reductions in pulmonary inflammation (BAL total leukocyte counts, and BALF IL-33 and 
IL-6 protein concentrations) and acute lung injury (total BALF protein) after 2 and 4 weeks 
of DFP treatment versus mice exposed to CS for the same duration but not treated with DFP 
(Fig. 6f, g and Supplementary Fig. 10c–e).
DISCUSSION
GWASs have provided compelling associations for multiple susceptibility loci associated 
with COPD; most of these loci, including IRP2 (15q25), family with sequence similarity 13, 
member A (FAM13A) and hedgehog interacting protein (HHIP), have been well-
replicated3,7,10,41–47. Here we characterize, for the first time the functional role of one of 
these genes, IRP2 (IREB2) in the pathogenesis of COPD. Consistent with increased IRP2 
expression in human subjects with COPD4, we confirm that Irp2 promotes COPD in two 
experimental mouse models of COPD.
Using novel experimental approaches, integrating unbiased IRP2-target identification in 
cells and mouse lungs with human COPD expression data, we demonstrate that IRP2 
regulates mitochondrial-related pathways in the lung. We validate this critical regulation in 
two well-established human COPD cohorts, showing a strong association between the 
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differential-expression of mitochondrial genes and IRP2 expression in COPD subjects (Fig. 
6h). Furthermore, we demonstrate that Irp2 promotes mitochondrial dysfunction in 
experimental COPD (Fig. 6h), which may ultimately lead to epithelial cell death and 
emphysematous destruction associated with COPD1. It is likely that cells in the lung that 
rely on mitochondrial function to promote cellular homeostasis maybe affected by increased 
IRP2 expression. Such cells may include ciliated epithelial cells of the respiratory tract that 
rely on mitochondria for adenosine triphosphate (ATP) generation for efficient ciliary beat 
frequency or parenchymal type II alveolar epithelial cells, which rely on their abundant 
stocks of mitochondria to regulate surfactant production. These data are consistent with 
earlier observations that increasing IRP2 is detrimental to cells48 and mice21 and that COPD 
itself is associated with mitochondrial dysfunction and altered mitochondrial 
dynamics17,49–51. Further investigations into the valency of the accumulating mitochondrial 
non-heme iron (that is Fe2+ or Fe3+) and the role of IRP2 in regulating mitochondrial heme 
biosynthesis will be important additional insights needed to fully elucidate the role of IRP2 
in regulating mitochondrial function in the lung.
Our data that IRP2 promotes mitochondrial iron overload in experimental COPD is 
consistent with previous observations that CS increases iron deposition systemically and in 
alveolar macrophages from human subjects with COPD52,53. Such iron deposition may also 
be consistent with recent reports of anemia being associated with poor clinical and 
functional outcomes in COPD54–56 and with reports that systemic inflammation in COPD 
up-regulates serum hepcidin57. Excess tissue or more specifically, excess mitochondrial iron 
may generate hydroxyl radicals that promote inflammation, cell death and oxidative stress21, 
all of which contribute to the pathogenesis of COPD1.
We hypothesize that as a consequence of sustained expression of IRP2, COX increases in 
airway epithelial cells and may become pathogenic, preceding and leading to mitochondrial 
dysfunction, epithelial cell damage, inflammation and emphysematous destruction in 
experimental COPD (Fig. 6h). In line with our observations, a recent study36 reported that 
high COX activity is required for maximal airway responsiveness36 and others have shown 
that COX is increased in skeletal muscle from human subjects with COPD58. We also 
illustrate that COX may be a central determinant in the lung for the regulation of 
mitochondrial iron in response to CS. Consistent with this notion, individuals with mutations 
in COX have abnormal regulation of iron (sideroblastic anemia35) and defects in 
mitochondrial heme biosynthesis59.
Finally, we highlight the efficacy of therapeutically targeting mitochondrial iron in COPD. 
Specifically, redistributing excessive mitochondrial iron using the membrane-permeant iron 
chelator DFP alleviated experimental COPD. This cytoprotective effect of DFP is intriguing 
amidst the availability of DFP for human use in the treatment of beta thalassemia40 and in 
various clinical trials. DFP can not only shuttle iron out of mitochondria, but can also shuttle 
iron between other cellular organelles such as nuclei and endosomes to extracellular 
apotransferrin. DFP can also mobilize iron from iron-loaded cells and donate it to pre-
erythroid cells for hemoglobin synthesis39,40. Mitochondrial-independent effects of DFP 
may therefore account for the synergistic effects of DFP with Irp2 deficiency in our 
experimental COPD model.
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Taken together, these studies provide valuable new insights into the mechanistic role of the 
COPD susceptibility gene IRP2 in experimental COPD. Our results strongly suggest that 
IRP2 is one of the potentially multiple COPD susceptibility genes located in the 
chromosome 15q25 COPD GWAS region. While GWASs generate clues to help us identify 
targets playing an important functional role in the pathogenesis of complex disease such as 
COPD, improved better integrative approaches to identify the key genes and functional 
genetic variants in GWAS loci are needed. Recent analyses indicate that the IRP2-15q25 
locus includes multiple genetic variants simultaneously associated with COPD and the 
expression of nearby genes (COPD eQTLs)60; it is therefore possible that multiple genes 
located in close proximity to IRP2 (for example, the nicotinic receptors cholinergic receptor, 
nicotinic, alpha 3 or CHRNA3 and CHRNA5) may influence COPD susceptibility.
Genes such as IRP2 that are involved in cigarette smoke-induced stress responses, 
particularly those converging on the mitochondria, act as first responders in cellular and 
possibly systemic iron processing which, if sustained for long periods of time, may have 
deleterious effects at the molecular, cellular and tissue level leading to mitochondrial 
dysfunction and subsequent cell death and the initiation of inflammation ultimately resulting 
in the development of COPD. Finally, our study strongly supports the use of mitochondrial 
iron chelators as novel therapeutic approaches for COPD.
ONLINE METHODS
Animals
Irp2−/− and WT littermate control mice were from a mixed genetic background consisting 
of 129S4/SvJae and C57Bl/6 and were from Tracey Rouault (National Institute of Child 
Health and Human Development). Sco2ki/ki (C57BL/6), Sco2ki/ko (C57BL/6) and WT 
(C57BL/6) littermate mice were from Eric Schon (Columbia University). Sco2ki/ki have a 
Sco2 knock-in (KI) mutation on both alleles and Sco2ki/ko have a Sco2 knock-in (KI) 
mutation on one allele and have Sco2 deleted on the other allele (KO)37. Wild-type 
(C57BL/6) and Fxnki/ko (C57/BL6) were purchased from Jackson Laboratories. Fxnki/ko 
mice harbor one allele of the frataxin (GAA) 230Δneo expansion mutation (Fxntm1.1Pand) 
on one chromosome, and one allele of the frataxin exon 4-deleted mutation (Fxntm1Mkn) on 
the homologous chromosome. All animals were housed in the same room and kept under a 
12-hour light/dark cycle. The iron content of the standard diet was 200 mg/kg. Power was 
not explicitly calculated for each experiment. Numbers of mice were typically chosen based 
on prior experiments. Cages were chosen at random for CS or RA exposures. We did not use 
a blinded approach during the CS exposure as mice needed to be monitored during and after 
smoke exposures. In addition, mouse cages exposed to CS displayed a distinctive smell and 
color and were obvious to the investigators.
In vivo CS exposures, chemical treatments and diet modifications—We selected 
age- and sex-matched mice, starting at 6–12 weeks of age, at random and exposed them to 
total body CS in a stainless steel chamber using a whole-body smoke exposure device 
(Model TE-10 Teague Enterprises) for 2 hours per day, 5 days per week for 4 weeks or 4–6 
months. Age-matched male and female mice were used for all CS exposures. Mice were 
exposed to CS (mainstream and side stream smoke) from 100 3R4F cigarettes (University of 
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Kentucky), which correlated to an average total particulate matter (TPM) of 150 mg/m3. For 
animals subjected to cigarette smoke exposure, early death was used as an exclusion 
criterion. At the end of the exposure regimen, we euthanized mice by CO2 narcosis, 
cannulated the tracheas and inflated the lungs with PBS at 25 cm of H2O pressure. We tied 
off the left lung with a suture, dissected it and place into liquid nitrogen. We fixed the right 
lung in 4% formalin at 4°C overnight. A proximal portion of the left lung (4 month 
exposures only) was fixed for transmission electron microscopy (TEM) analysis.
Mice exposed to CS for 4 weeks had modifications to their dietary iron as follows: Diet 1 
(Control Diet) from Harlan Laboratories (TD.94045 AIN-93G), which contained 300-ppm 
iron. Diet 2 (iron deficient diet) from Harlan Laboratories (TD.10210), which contained 2–6 
ppm iron. Diet 3 (iron replete Diet) from Harlan Laboratories (TD.10213), which contained 
2 % carbonyl iron. Iron diets were exchanged for normal diets upon weaning at 3 weeks of 
age and used throughout the smoke exposures. We weighed each animal on a weekly basis 
and the we recorded the quantity of chow consumed comparing it to mice on a normal iron 
diet. We administered deferiprone or Ferriprox® solution (1mg/ml) (ApoPharma Inc.) 
prophylactically in the animals’ drinking water for the duration of smoke exposure. We also 
administered deferiprone therapeutically in the animals’ drinking water initiating therapy 
after 4 weeks of smoke exposure and continuing therapy for an additional 2–4 weeks. 
Animals were checked daily and the quantity of water consumed compared to control mice. 
Water solutions were changed twice weekly.
Hyperoxia exposures—We exposed age- and sex-matched Irp2−/− and WT littermate 
mice (129S4/SvJae and C57Bl/6 background), starting at 10 weeks of age, selected at 
random to hyperoxia (> 99% O2) at a flow rate of 12 liters/min in a 3.70-ft3 Plexiglas 
exposure chamber61, with access to chow and water ad libitum. We assessed survival by 
checking mice at regular intervals over 0–120 hours.
Cecal ligation puncture (CLP) sepsis model—CLP was done as described62. Briefly, 
under aseptic conditions, we incised the abdominal skin and dissected the abdominal 
muscles of age- and sex-matched Irp2−/− and WT littermate mice (129S4/SvJae and 
C57Bl/6 background), starting at 10 weeks of age, selected at random to gain access to the 
peritoneal cavity. We located the mouse cecum and we ligated 75% of it with a 6-0 silk 
suture and perforated it with a 21 G needle by one through-and-through puncture (two holes) 
near to the ligation. Sham operated mice underwent the same procedure without ligation and 
puncture of the exposed cecum. After surgery, we i.p. injected 1 ml of pre-warmed (37 °C) 
normal saline to restore heat and hydration of operated mice.
All animal experimental protocols were approved by the Harvard Standing Committee for 
Animal Welfare and by the Institutional Animal Care and Use Committees of Brigham and 
Women’s Hospital.
Electrophoretic Mobility Shift Assay (EMSA)
Irp2 EMSAs were carried out using the LightShift® Chemiluminescent RNA EMSA Kit 
(Thermo Scientific) with a biotinylated IRE, according to the manufacturers instructions. 
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Supershift assays were carried out using 2.5 μg of anti-Irp2 IgG (NB100-1798, Novus 
Biologicals).
Immunohistochemistry and immunofluorescence staining
We prepared and stained formalin-fixed, paraffin-embedded 5-micron-thick lung sections 
using standard procedures. Briefly, sections were deparaffinized through graded alcohols 
and washed in PBS. Heat-activated antigen retrieval was performed in a microwave oven 
using a citrate buffer (Target Retrieval Solution, S1699, DAKO) for 10 minutes. 
Endogenous peroxidases were blocked using a peroxidase blocker (DAKO Cytomation), and 
the slides were blocked for nonspecific protein binding by incubating in 10% normal serum 
for 45 minutes. Tissues were immunostained with a rabbit primary IgG to Irp2 (LS-B48, LS 
Bio) at a 1:50 dilution or with mouse anti-cytochrome C, (556433, BD Biosciences) at a 
1:250 dilution or with rabbit monoclonal IgG to cytochrome C EPR1327 (D00355 Abcam) 
at a 1:50 dilution, or with rabbit anti-LC3B (L7543, Sigma Aldrich) at a 1:400 dilution and 
signals were developed using the VECTASTAIN Elite ABC Kit (PK-6101; Vector 
Laboratories), according to the manufacturers protocol. Hematoxylin and Eosin stains were 
purchased from Sigma Aldrich and staining was carried out as per manufacturer’s 
instructions. The negative control consisted of substituting PBS for the primary antibody.
Epifluorescence microscopy—Briefly, tissues were stained with goat polyclonal IgG to 
Irp2 (ab106926, Abcam) at a 1:50 dilution or rabbit monoclonal IgG to Irp2 (ab181153, 
Abcam) at a 1:50 dilution. Co-staining for type II epithelial cells was carried out using a 
rabbit polyclonal IgG to prosurfactant protein C (Pro-SPC) (ab90716, Abcam) at a 1:50 
dilution and for type I epithelial cells using anti-mouse podoplanin alexa Fluor® 488 IgG 
(53-5381-80, Affymetrix) at a 1:500 dilution. Co-staining for Irp2 and markers of ciliated 
airway epithelial cells was conducted using a rabbit IgG for acetyl-α-tubulin (Lys40) 
(D20G3, Cell Signaling) at a 1:50 dilution, and co staining for non-ciliated secretory 
epithelial cells was conducted using a rabbit polyclonal IgG to uteroglobin (ab40873, 
Abcam) at a 1:100 dilution. Secondary staining was carried out using goat anti-rabbit IgG (H
+L) rhodamine red conjugate (R-6394, Life Technologies) at a 1:500 dilution or donkey 
anti-goat IgG (H+L) secondary antibody, alexa Fluor® 488 conjugate (A-11055, Life 
technologies) at a 1:500 dilution. Nuclei were counter-stained using TO-PRO®-3 Iodide 
(T3605, Life Technologies) at a 1:1000 dilution or Hoechst (33342, ThermoFisher 
Scientific) at a 1:300 dilution.
Morphometric analysis of lung sections
Formalin Fixed lung samples were cut parasagitally and embedded in paraffin. We 
performed Modified Gills staining as described previously63. We quantified air space 
enlargement using the mean linear intercept (chord) length (MLI or Lm) method63 or using a 
previously published, automated image-processing algorithm that calculates the area 
weighted mean diameter or D2 index64. Briefly, randomized images were acquired 
(Axiophot; Carl Zeiss Micro- Imaging equipped with a digital camera Axiocam HRc; Carl 
Zeiss MicroImaging) as black and white TIFF files using a microscope, a 20 × objective, 
and a camera and software that can acquire high-quality digital images. 20–30 images (× 
200 magnification) were captured per mouse in a randomized manner, with the observer 
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blinded to the experimental condition, avoiding under-inflated areas of the lung (at 20 × 
magnification). Lung sections were blinded by taping the slide identifiers before acquiring 
images and before data analysis. Random number generations using excel and a gridded 
coverslip were used to choose the sample image area for acquisition in all cases.
Mean Chord Length measurements—This protocol measures mean alveolar chord 
length and alveolar area on paraffin-embedded lung sections stained with Gill’s stain. 
Morphometry software converts images of lung sections to binary images (in which tissue is 
white and airspace is black), and then superimposes a uniform grid of horizontal and vertical 
lines (chords) and the software then quantifies the length of each chord within areas 
identified by software as airspace65. Using this method, it is possible to measure the size of 
the alveoli in all parts of the lung in a standardized and relatively automated manner65. 
Airspace enlargement was quantified using the MLI method using Scion Image and 
customized macros to analyze airspace enlargement65. Large airways, blood vessels, and 
other non-alveolar structures were manually removed from the images. The alveolar chord 
length macro was adapted from the macro available in NIH Image. Alveolar chord length for 
each image was calculated and the average mean chord length +/− s.e.m. for each mouse 
calculated.
Measurement of alveolar diameters—This protocol measures the area weighted mean 
diameter or D2 index. Compared to the Lm, the D2 index characterizes the heterogeneity in 
airspace sizes, has been used in the past to quantify airspace enlargement in many 
studies66–70, where it has a higher sensitivity and specificity for discerning airspace 
enlargement in smoke-exposed mice66. In this study, the D2 index was calculated on 
paraffin-embedded lung sections stained with Gill’s stain with randomized image 
acquisition as described above. The histological images were first thresholded to create a 
black and white image where white pixels correspond to air and black pixels correspond to 
tissue. To avoid errors associated with non-uniform illumination each image was split into 
non-overlapping blocks and the threshold for each block calculated using the Otsu’s method, 
which calculates the optimum threshold to minimize the intraclass variance of the black and 
white pixels71. The black and white images were then used to calculate a signed distance 
function where each pixel is assigned the negative of the distance to the nearest black 
(tissue) pixel. The resulting distance function had a deep minima near the center of each 
alveolar section and also many shallow local minima close to the alveolar walls created by 
small local fluctuations in curvature of alveolar walls. The shallow minima were removed 
by a morphological operator called the H minima transform72. The resulting modified 
distance map was then segmented using the watershed algorithm73 into distinct regions with 
each region corresponding to a section of an alveolus. The area occupied by each alveolar 
section was measured by counting the number of pixels in each region. The measured area 
was then converted to real units (O (micron2) for mouse alveolar sections) by multiplying 
with a scaling factor. The area of each alveolar section A was then converted to an 
equivalent alveolar diameter, d as . From the measured equivalent diameters the 
area weighted mean diameter D2 as  was calculated.
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Small Air remodeling—We used a modification of a published morphometry method65,74 
to quantify small airway remodeling in formalin-fixed lung sections from WT, and Irp2−/− 
mice exposed to RA or CS for 6 months. Briefly, lung sections were stained with Masson’s 
Trichrome stain (Sigma-Aldrich) and images acquired using a light microscope (Axiophot; 
Carl Zeiss Micro- Imaging) equipped with a digital camera (Axiocam HRc; Carl Zeiss 
MicroImaging) at 200× magnification by a blinded experienced reader as previously 
described65. MetaMorph software (Molecular Device LLC) was used to measure the mean 
airway luminal diameter and the thickness of the sub-epithelial fibrosis layer stained blue by 
Masson’s Trichrome stain at 12 separate sites around the airway by a different blinded 
experienced reader. The mean (± s.e.m.) thickness of the sub-epithelial layer in microns was 
calculated for airways having a mean internal diameter between 300 and 699 microns. 
Sections of airways sharing their adventitia with arteries or other airways were not included 
in the analysis.
BALF isolation, cell counts and ELISA
Mice were euthanized by CO2 narcosis, the tracheas cannulated and the lungs lavaged with 
0.5 ml increments of ice-cold PBS eight times (4 ml total). BALF was centrifuged at 500 xg 
for 5 minutes. 1 ml red blood cell lysis buffer (Sigma Aldrich) was added to the cell pellet 
and left on ice for 15 minutes followed by centrifugation at 600 xg for 3 minutes. The cell 
pellet was resuspended in 500 μl PBS and leukocytes were counted using a hemocytometer. 
Specifically, 20 μl was removed for cell counting performed in triplicate using a 
hemocytometer and 80 μl removed for cytocentrifuge preparations (Shandon Cytospin3, 300 
rpm for 5 minutes) and stained using the Hema3 staining system (Fisher Scientific). The 
percentage of macrophages, lymphocytes and polymorphonuclear leukocytes (PMNs) were 
counted in a total of 300 cells, and absolute numbers of each leukocyte subset were 
calculated.
Commercial ELISAs were used to measure the following analytes in duplicate in 
homogenates or BALF of lung samples from mice following the manufacturer’s 
instructions: MMP-9 (Mouse Total MMP-9 DuoSet, DY6718 R&D Systems), cleaved 
caspase 3 (Human/Mouse Cleaved Caspase-3 (Asp175) DuoSet IC, R&D Systems 
DYC835-2), IL-6 (mouse IL-6 DuoSet R&D Systems DY406), IL-33 (mouse IL-33 DuoSet, 
R&D Systems DY3626-05), IL-18 (IL-18/IL1F4 ELISA kit 7625, R&D diagnostics) and 
IL-1β (Mouse IL-1 beta/IL-1F2 R&D Systems DY401-05).
Assessment of Mucociliary Clearance
Mucociliary clearance was quantified using a non-invasive, oropharyngeal aspiration 
procedure described previously18. Briefly, we anesthetized mice and introduced 50 μl of 
normal saline containing approximately 0.3–0.5 mCi of 99mTechnetium sulfur colloid 
(99mTc-SC) (Brigham and Women’s Hospital) into the distal part of the oropharynx by 
aspiration. We immediately imaged mouse lungs after aspiration (time 0 hours), at 1 hour 
and 3 hours. Whole mouse 3D μ-single-photon emission computed tomography (SPECT) 
images from 10 minute acquisitions at 0, 1, and 3 hour time points were obtained, 
reconstructed, blindly analyzed and expressed as the percent removed by mucociliary 
clearance. Regional lung deposition of 99mTc-SC characterized by calculating the central 
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(area closest to the trachea) to peripheral airway distributions ratio (C:P ratio) was corrected 
for, as described previously75. To correct for any abnormality in distribution, MCC rates 
were corrected for C: P differences using standard multi-variable linear regression76.
RIP-Seq
Three 15 cm2 dishes (1.5×106 cells) of Beas2B cells (purchased from ATCC) treated with or 
without 10 μM DFO (16 hours) were washed with ice cold PBS and collected into 2 ml 
eppendorfs by scraping. We carried out RNA immunoprecipitation using the Magna RIP™ 
RNA-Binding Protein Immunoprecipitation Kit (Millipore). 4 μg of mouse Irp2 IgG (7H6: 
sc-33682, Santa Cruz) or 4 μg of IgG mouse control antibody (sc-2749, Santa Cruz) were 
added to supernatants and incubated overnight at 4°C. We extracted RNA from Magna 
RIP™ beads by Trizol extraction. Samples (n = 2 biological replicates) were prepared for 
RNA-Seq using the TruSeq RNA-Seq Lib Prep Reagent (Illumina) and sequencing 
performed on the Illumina HiSeq2000 platform. Sample preparation and sequencing was 
carried out by The Center for Cancer Computational Biology, Dana-Farber Cancer Institute, 
Boston, MA (cccb.dfci.harvard.edu). RIP-Seq data (GEO accession number GSE57073) was 
analyzed as follows. Sequenced reads for two biological replicates each in CTL and DFO 
samples, as well as CTL-IgG and DFO-IgG, were aligned to the human hg19 known 
transcriptome using bowtie2-2.0.6 and tophat-2.0.7.Linux_x84_64. Any unmapped reads 
were then allowed to map to the hg19 genome. Aligned reads were then combined from 
replicates and HOMER (http://biowhat.ucsd.edu/homer/ngs/index.html) was used to identify 
and annotate “peaks”, or regions enriched for reads in one sample compared to another. 
Peak-calling was performed on the aligned reads, resulting in the identification of 3497 
“common” peaks (mapping to 1806 genes) that were shared between the control (CTL) and 
DFO samples as well as CTL-specific peaks and DFO-specific peaks. Validation of our data 
included the detection of peaks in known IRP2 targets, including ferritin and TfR 
(Supplementary Fig. 4e, f). We also estimated the percentage of peaks with the known IRE 
binding motif (CAGWGH)77.
Four primary comparisons were made: CTL compared to CTL-IgG (CTL/IgG), DFO 
compared to DFO-IgG (DFO/IgG), CTL compared to DFO (CTL/DFO) and DFO compared 
to CTL (DFO/CTL). The first two comparisons identified where IRP2 is bound in either 
CTL or DFO, whereas the latter two comparisons highlight where IRP2 is uniquely bound in 
only CTL or DFO (Supplementary Fig. 4d). In each comparison a peak was associated with 
a genomic region if that peak had a two-fold tag enrichment relative to the input sample, a 
Poisson P -value less than 0.1 and a peak-score (position-adjusted read counts) greater than 
5.
To build a robust set of peaks for further analysis, we identified peaks common between 
different comparisons using HOMER’s ‘mergePeaks’ function. 3497 “common” peaks 
where IRP2 is bound in both CTL and DFO, we identified as shared between the CTL/IgG 
and DFO/IgG comparisons. CTL-specific peaks and DFO-specific peaks were identified by 
determining peaks common to the CTL/IgG and CTL/DFO or the DFO/IgG and DFO/CTL 
comparisons respectively (Supplementary Fig. 4d). For peaks belonging to one of these 
three sets, we used HOMER’s ‘annotatePeaks’ function to scan the genomic sequence of the 
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peak regions for the known IRE binding motif (CAGWGH)77 and to map peaks to their 
target genes. Common peaks mapped to 1806 unique gene transcripts and CTL-specific and 
DFO-specific peaks mapped to 2203 and 2135 unique gene transcripts, respectively 
(Supplementary Fig. 4d).
Gene Expression Microarray Analysis
The GeneChip® Mouse Gene 1.0 ST Array (Affymetrix) was used to assess gene expression 
in the Irp2−/− and WT mice. RNA was isolated from lungs harvested from WT age-matched 
(n = 3 males, 3 females) and Irp2−/− (n = 3 males, 3 females) using the RNeasy Mini Kit 
(Qiagen). The gene expression data GEO accession number GSE57048, was analyzed as 
follows. GSE57048 was Robust Multi-array Average (RMA)-normalized and probe-sets 
mapped to Entrez-gene IDs using a custom CDF78. To compare the expression data to the 
RIP-Seq data, we selected 16573 genes on the expression array that belong to a single 
conserved homologous group (http://www.ncbi.nlm.nih.gov/homologene/) with the 
corresponding human homolog identified. For these genes the expression difference between 
the Irp−/− and WT mice was quantified using an unpaired two-tailed t -test.
Functional Enrichment Clustering Analysis
To evaluate how IRP2 may affect the activity of cellular pathways in the lung, we carried 
out functional enrichment analysis using the Database for Annotation, Visualization, and 
Integrated Discovery (DAVID)79 tool79,80. DAVID analysis (http://david.abcc.ncifcrf.gov) 
was carried out on the genes in each of three RIP-Seq defined sets (CTL, DFO and 
Common), both independently and combined. To better interpret the results of this analysis, 
the fast-greedy community structure algorithm81 was applied to a network defined by the 
GO annotations between the genes identified in the RIP-Seq analysis and the GO terms 
identified as enriched (False discovery rate (FDR)<1×10−3) in the DAVID analysis on the 
combined gene set. This network analysis resulted in the identification of five 
“communities” containing related sets of genes and terms (Supplementary Fig. 4g). For each 
“community” identified in the RIP-Seq data, the values of the t -statistic for genes in the 
community was compared to those not in the community, and a “meta”-t -statistic and 
associated p-value was computed representing the significance of the association of the 
Irp2−/− versus WT differential-expression with genes in each of the RIP-Seq 
“communities”82 (Fig. 2b). This analysis revealed a strong association between differential-
expression and genes in community 2.
Next we selected the genes belonging to community 2 that are also strongly differentially 
expressed (P < 0.01) in Irp2−/− compared to WT mice. We examined to which GO 
categories (Gene Ontology terms83) these genes are annotated, and made three heat maps 
(Fig. 3a and Supplementary Fig. 5) based on whether they are annotated to mitochondrial 
functions (Fig. 3a), protein localization functions (Supplementary Fig. 5a) or other functions 
that belong to community 2 (Supplementary Fig. 5b). In each heat map, the rows were z-
score normalized to aid in visualizing differences in expression values.
As RIP-Seq was based on a specific IRP2 antibody that immunoprecipitated IRP2-mRNA 
complexes only (subtracting IgG-mRNA complexes as background) and then was followed 
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by a comparison to the baseline gene expression in WT versus Irp2−/− lungs, the effects of 
DFO are therefore not confounded on the functional enrichment clustering analysis carried 
out in this study and the results are related to IRP2 only. Specifically, 83% (34 of 41) of the 
genes we show in Fig. 3a were identified as a target of IRP2 in the CRTL v’s Igg 
comparison (so they were either in the “common” or in the “CTRL-only” peaks, or both). 
Only 7 genes were identified in the DFO-only peak set.
Circos Plot generation
Using the DAVID output from the combined gene-set analysis, a Circos plot was generated 
to graphically demonstrate the gene transcripts and pathways enriched and/or altered in our 
CTL-specific (blue), DFO-specific (red) and common (purple) data sets. The inner ring of 
the Circos plot is colored to represent the five identified functional communities. Since each 
gene belongs to only one community, genes were assigned to segments of the circle located 
within their “community”. Other genomic information associated with these genes, such as 
COPD differential expression and RIP-Seq peak scores, was then visualized on different 
“rings” aligned over these genes.
LGRC gene expression (mRNA) Circos Plots—To identify any common pathways 
that may be dysregulated by IRP2 in subjects with COPD, on the Circos plot we included 
gene expression data (mRNA) (Fig. 2a) from lung tissue of individuals with COPD and 
controls from the Lung Genomics Research Consortium (LGRC; http://lung-genomics.org/
research). The Lung Genomics Research Consortium (http://lung-genomics.org/research) 
utilized lung tissue samples from the Lung Tissue Research Consortium and was sponsored 
and approved by the National Heart, Lung and Blood Institute. Lung tissue mRNA 
expression data was downloaded from the publicly available LGRC data set GSE47460 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47460). This 159 mRNA gene 
expression data set contained n = 121 COPD, n = 20 non-smokers and n = 18 smokers. We 
calculated the fold-change difference between the expression values for each gene in the 
COPD versus control samples; the inner ring (black ring) of the Circos plot shows the fold-
change for genes containing an identified IRP2 peak. Genes with fold-change of more than 
1.5 or less than 1/1.5 were highlighted (green denotes lower than COPD, magenta denotes 
higher in COPD). Circos plot generation allowed for the visualization of similarities and 
differences between the CTL (blue), DFO (red), common (purple) RIP-Seq peak sets and 
human COPD RNA-Seq (black).
Phenotypic Characterization of emphysema and source of tissue
The LGRC provides genetic, molecular, and quantitative phenotype data as well as 
exclusion criteria, for human subjects in the NHLBI’s Lung Tissue Research Consortium 
(LTRC) biorepository (www.lung-genomics.org). Lung tissue samples were collected as 
part of the routine care of patients and submitted with a standardized series of questions. In 
addition to standard spirometry, DLCO data were available. For controls we included only 
individuals with a DLCO greater than 80% and for cases DLCO less than 80%.
As previously mentioned, the LGRC mRNA gene expression data set used the publicly 
available http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47460 data set. The 159 
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mRNA gene expression data set contained n = 121 COPD, n = 20 non-smokers and n = 18 
smokers with phenotypic information along with LTRC overall final pathologic diagnosis 
(CPAL1) as follows.
CPAL1 Emphysema, centrilobular Granulomatous Inflammation (NOS) Normal Other
COPD 113 2 0 6
Non-Smoker 13 1 4 2
Smoker 14 2 1 1
Distributional location of the lung tissue resection (right or left upper or lower lobe), along 
with pathological diagnosis is described below.
Site Lingula Left Lower Left Upper Right Lower Right Middle Right Upper
COPD 1 10 31 14 1 64
Non-Smoker 0 3 3 7 2 5
Smoker 0 3 7 3 1 4
Validation of mitochondrial genes in two COPD Cohorts
To compare our identified mitochondrial genes in human COPD lung tissue with high or 
low IRP2 expression, we used two independent COPD cohort data sets of gene expression.
COPD data set 1—We used publicly available gene expression data from the LGRC 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47460). Data collected using each 
of the two array platforms included was background corrected and then normalized between 
arrays using limma84. Next we removed duplicate probes and matched between the two 
array platforms based on gene name. This merged dataset was then corrected for array-
specific batch effects using ComBat85. Of the 580 subjects included in this publicly 
available data, we identified those with a COPD diagnosis or “control” status (219 and 107 
individuals respectively). Approximately half of these subjects were subsequently removed 
based on quality control, leaving us with a 159 subject mRNA gene expression data set 
contained n = 121 COPD, n = 20 non-smokers and n = 18 smokers. In this final dataset all 
subjects with COPD had a DLCO less than 80% and all controls (both smokers and non-
smokers) had a DLCO greater than 80%.
COPD data set two—We also used gene expression data from the ECLIPSE (Evaluation 
of COPD Longitudinally to Identify Predictive Surrogate End-points) Study. This study was 
a 3-year observational study86, where emphysema-predominant COPD was defined by 
>10% of lung voxels with attenuation ≤ −950 HU on inspiratory chest CT scans. Other 
assessments include pulmonary function measurements (spirometry, impulse oscillometry, 
chest computed tomography, biomarker measurement (in blood, sputum, urine and exhaled 
breath condensate), health outcomes, body impedance, resting oxygen saturation and 6 
minute walking distance86. CEL expression files from ECLIPSE (GSE54837: http://
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www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54837), with “phenotype” information 
(http://www.ncbi.nlm.nih.gov/geo/geo2r/?acc=GSE54837)86. This particular data set 
contained n = 136 COPD subjects, n = 84 Smoker Controls, n = 6 non-smoker controls. The 
ECLIPSE data was RMA-normalized using a custom CDF.
Raw expression data from the two COPD cohorts was downloaded, including raw data files 
(.TAR) from LGRC (GSE47460), and CEL expression files from ECLIPSE (GSE54837); 
the ECLIPSE data was RMA-normalized using a custom CDF. We identified which of our 
selected mitochondrial genes (Fig. 3a) were measured in each of these cohorts and show 
their expression levels in ECLIPSE and LGRC (Fig. 3b–c and Supplementary Fig. 6) within 
different subject populations. In each heat map, the subjects are ordered (from left to right) 
based on increasing values of IRP2 gene expression, with a white bar delimiting which 
individuals were identified as having “low” IRP2 expression (less than the median across all 
subjects) or “high” IRP2 expression (greater than the median across all subjects). Rows are 
ordered the same as Fig. 3a and each row is Z-score normalized for visualization purposes 
(Supplementary Fig. 6).
For LGRC gene expression data set the overall “meta” p-values (for the genes in the heat 
map) were: COPD-subjects: 1.4e–3, Smoker-controls: 0.9564, Non-smoker controls: 0.5303 
(Supplementary Fig. 6a). For the ECLIPSE data set the overall “meta” p-values (for the 
genes in the heat map) were: COPD-subjects: 1.4088e–7, Smoker-controls: 6.1838e–6, Non-
smoker controls: 1.6108e–5 (Supplementary Fig. 6b). In all cases the overall differential 
expression is consistent with observations in the Irp2−/− vs. WT mice (overall decreased 
expression of these genes in “low” IRP2 compared to “high” IRP2, corresponding to more 
green on the left of the heat maps.
Finally, we also compared our results with a earlier published study that defined a 127 gene 
expression signature associated directly with increases in Lm from microCT information of 
COPD subjects as reported by Campbell et. al87. While IRP2 was not enriched in the 127-
gene expression list in Campbell et. al 2012, it had an FDR of <1 (0.63) and a t-statistic of 
−1.44. On this list, IRP2 (IREB2) was ranked 2475 (out of 17879) based on the fold-change 
and 2282 (out of 17879) based on the t-statistic value. When we examined the 127 gene-
expression signature from Campbell et. al. for common gene targets identified by our RIP-
Seq study, we noted that 114 of the genes in this expression-signature were included in the 
annotations used by HOMER when mapping our peak calls. Of these 114 genes, 27 had an 
identified IRP2 peak in our data, an overlap that is marginally significant (P = 0.06, Fisher’s 
Exact Test). When investigating the three sets of peaks separately (CTRL, DFO, and 
Common), there was a strong significant overlap (18 genes, P = 1.6e–3) between the 127 
genes in the expression-signature and the genes that had “common” peaks of IRP2. Further, 
within the 27 genes in the gene-expression signature that also had an identified IRP2 peak 
there was a relative enrichment for genes with decreased expression with increased 
emphysema severity (21/27 or 78% of genes in the expression signature that have an IRP2 
peak have decreased expression with increased emphysema severity, compared to 73/114 or 
64% of all genes in the full expression signature). This was highly driven by genes with 
peak-calls in the DFO experiment; all 12 genes in the gene-expression signature that had a 
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DFO peak were found to have decreased expression levels with increased emphysema 
severity.
Human Samples and Study Approval—Human Lung tissues were analyzed under the 
guidelines of Brigham and Women’s Hospital Institutional Review Board (IRB) approval. 
Human samples were classified based on the guidelines of the Global Initiative for 
Obstructive Lung Disease as previously described17,18,22. Human samples obtained from the 
Lung Genomics Tissue Research Consortium (LTRC) used in Fig. 5a were homogenates 
from GOLD2 tissues obtained from open lung biopsies and are described in Supplementary 
Table 2 (adapted from Lam et al18). The Lung Genomics Research Consortium (LGRC) 
provides genetic, molecular, and quantitative phenotype data for human samples in the 
National Heart, Lung and Blood Institute LTRC biorepository (www.lung-genomics.org). 
Informed consent was obtained from all subjects included in these studies.
Transmission electron microscopy
Tissues from mice exposed to chronic CS were fixed overnight at 4°C using TEM grade 
fixative solution of 2% formaldehyde and 2.5% glutaraldehyde in 0.1 M sodium cacodylate 
buffer, pH 7.4. The samples were washed and stored in 0.1 M sodium cacodylate buffer and 
kept at 4 °C until processing. Sample embedding was performed using a standard protocol 
as previously described18. For EM quantification, 15 image fields were selected at random 
by a blinded reader for each mouse or sample (n = 1 mouse per group). Specifically, a 
blinded code was generated by the TEM core facility and images acquired by an 
experienced core facility technician. SMC analyzed slides using a blinded key. The total 
area of the cytoplasm was calculated, and the number of mitochondria with ‘abnormal’ 
characteristics (defined as mitochondria with swollen or abnormal cristae) per unit area of 
cytoplasm were counted using ImageJ.
Cell Culture, siRNA, shRNA and CSE
Primary epithelial cells were isolated from mouse lungs as previously described and used for 
experiments before passage17. Primary Human Bronchial Epithelial cells (HBE) cells were 
obtained from ATCC and were cultured according to ATCC’s instructions. Human lung 
bronchial epithelial Beas-2B cells were purchased from ATCC and maintained in DMEM 
containing 10% FBS and gentamicin (100 μg/ml). Beas2B and HBE cell lines were 
authenticated and checked for mycoplasma infection. Beas2B cells were treated with siRNA 
targeted to human IRP2 (SMARTpool: ON-TARGETplus IREB2 siRNA L-022281, 
Dharmacon, GE Healthcare) for 48 hours using Lipofectamine® RNAiMAX Transfection 
Reagent (Life Technologies) using standard transfection techniques. shRNA targeted to 
human IREB2 was from Sigma Aldrich (NM_004136, iron-responsive element binding 
protein 2 MISSION® shRNA). MISSION shRNA clones in shRNA lentiviral plasmids 
(pLKO.1-puro) were purchased as frozen bacterial glycerol stocks in Escherichia coli for 
propagation and downstream purification of the shRNA clones. shRNA viral particles were 
generated using standard procedures and cells containing positive shRNA clones were 
selected for using puromycin.
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CSE was prepared and added to culture media as previously described63,88. Briefly, a 
peristaltic pump (VWR International) was used to bubble mainstream smoke from five 
3R4F cigarettes with filters removed through 50 ml DMEM. Each cigarette was smoked 
within 6 minutes until approximately 17 mm remained. The extract was filter sterilized, 
stored at −80 °C, and used immediately upon thawing. The CSE generated in this fashion 
was considered 100% strength and was diluted in complete DMEM media for cell treatment.
Measurement of mitochondrial membrane potential and Cytochrome C oxidase activity
Mitochondrial-enriched fractions were isolated from the lungs of mice and JC1 uptake 
measured using the MITOISO1 mitochondrial isolation kit (Sigma Aldrich). Mitochondrial 
membrane potential was measured in primary epithelial cells using tetramethylrhodamine 
ethyl ester (TMRE) (Abcam). Briefly, cells were treated with CSE or 20 μM carbonilcyanide 
p-triflouromethoxyphenylhydrazone (FCCP) for the indicated times and stained for 20 
minutes at 37°C with 150 nM TMRE. Data were acquired with a FACSCanto II (BD 
Biosciences) and analyzed with FlowJo analytical software (Tree Star Inc.). Cytochrome C 
oxidase activity was measured in mitochondrial-enriched fractions using an optimized 
colorimetric assay based on the decrease in absorbance of ferrocytochrome c measured at 
550 nm, which is caused by its oxidation to ferricytochrome c by cytochrome c oxidase 
(Sigma Aldrich).
Seahorse analysis
Extracellular acidification rates and oxygen consumption rates were determined by the 
Seahorse XF 96 flux analyzer (Seahorse Bioscience). Primary airway epithelial cells were 
isolated as described above and plated onto cell culture microplates (Seahorse Bioscience) 
coated with 50 ng/μl Laminin 1 (3400-010-01, Trevigen) for 4 days (media change on Day 
2). On the day of the experiment cells were treated with CSE for 4 hours. Cells were 
incubated in XF assay medium (Seahorse bioscience), supplemented with 5 mM glucose, 4 
mM glutamine and 1 mM pyruvate for one hour prior to the measurement. After the 
recording of the basal rates of ECAR and OCR, final concentrations of 1 μM oligomycin, 2 
μM carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP) and 0.5–0.5 μM 
rotenone and antimycin A were added (Sigma) through the instruments injection ports in 
order to obtain proton leak, maximal respiratory capacity and non-mitochondrial respiration 
respectively. Rates were normalized by DNA with Hoechst 33342 against standards with 
known concentrations of DNA.
Perls’ stain and non-heme iron measurements
Formalin-fixed, paraffin-embedded 5-micron-thick lung sections were deparaffinized 
through graded alcohols and washed in PBS. Slides were incubated in Perls’ stain (5% 
potassium ferrocyanide with 5% hydrochloric acid) for 30 minutes at RT. 500 μl of nuclear 
fast red solution was added to each slide and incubated for 4 minutes. Slides were 
dehydrated using graded alcohols and samples viewed by a blinded experienced reader using 
a light microscope (Axiophot; Carl Zeiss Micro- Imaging) equipped with a digital camera 
(Axiocam HRc; Carl Zeiss MicroImaging) at 200× magnification. Perls’ stain reacts with 
iron to form a blue-black color. Staining was quantified in n = 3–4 mice per group (n = 10 
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20× images per mouse) by a blinded experienced reader and staining quantified using the 
Threshold feature in Image J. Lung sections were blinded by taping the slide identifiers 
before acquiring images and before data analysis. Random number generations using excel 
and a gridded coverslip were used to choose the sample image area for acquisition in all 
cases.
Non-heme iron assay—Lung tissue (50–200 mg) or 50–200 μl subcellular fractions were 
incubated with 100–500 μl of NHI Acid (10% trichloroacetic acid in 3 M HCl) overnight at 
65 °C. Samples were cooled, vortexed and centrifuged at 2,000 rpm for 15 seconds. Equal 
volumes of sample or iron standard (25 μg/ml–0.39 μg/ml using NHI Acid) were incubated 
in a 1-ml cuvette for 5–10 minutes at RT with 800 μl BAT Buffer (0.2% thioglycolic acid, 
0.02% bathophenanthroline sulfonate in 1/2 saturated NaAc solution). Samples were read at 
535 nm with unknowns calculated from a standard curve.
Heme iron assay—Heme iron was measured in isolated mitochondrial and cytosolic 
fractions using the QuantiChrom™ Heme Assay Kit (BioAssay Systems) according to the 
manufacturers instructions. Briefly, heme iron was measured in 10 μl mitochondrial and 
cytosolic fractions by measuring intensity at 400 nm against a standard curve of known 
concentrations of heme.
Measurement of Labile Iron Pool using Calcein-AM—The labile iron pool of 
Beas2B cells was measured as previously described89. Briefly, 106 Beas2B cells were 
seeded in 10 cm dish, left overnight, harvested by trypsanization, counted and resuspended 
in serum free DMEM. Cells were incubated with 0.5 μM CA-AM at 37 °C for 8 minutes 
with constant agitation before washing with Hanks’ Balanced Salts (HBS) solution 
(containing phenol red). Cells were resuspended in HBS and incubated with trypan blue (25 
μg) to block extracellular fluorescence. Fluorescence was measured at 517 nm emission, 488 
nm excitation, measuring the blank rate before the addition of 100 μM salicylaldehyde 
isonicotinoyl hydrazine (SIH). The change in fluorescence (Δ F) upon SIH addition was 
calculated for each sample. In cells without trypan blue, a series of increasing concentrations 
of calcein were added sequentially and the Δ F calculated to construct a calcein v’s Δ F 
standard curve.
Immunoblotting
Immunoblot analyses were performed in whole lung homogenates or mitochondrial-enriched 
fractions isolated from the lungs of mice using standard immunoblotting techniques with the 
following antibodies: Irp2 (1:1000 7H6: sc-33682, 1:1000 Santa Cruz, NB100-1798, Novus 
Biologicals and Irp2 antibody from Tracey Rouault at a 1:1000 dilution), Irp1 (1:1000 
NBP1-19412, aconitase 1 Antibody, Novus Biologicals), LC3B (1:2000 L7543, Sigma 
Aldrich), Atg 7 (1:2000 APG7 (H-300): sc-33211, Santa Cruz), transferrin receptor 1 
(1:1000 CD71 (H-300): sc-9099, Santa Cruz), actin (1:10,000 A00158, Sigma Aldrich), 
electron transport chain components including COX MTCO1 (1:500 MitoProfile® Total 
OXPHOS antibody, ab110413, Abcam), ferritin (1:1000 H-53: sc-25617, Santa Cruz), 
tom20 (1:2000 FL-145, sc-11415, Santa Cruz), frataxin (1:1000 H-155: sc-25820, Santa 
Cruz), mitoferrin 2 (1:1000 P-12: sc-138430, Santa Cruz), cleaved- caspase 3 (1:500 
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Asp175, Cell Signaling technologies), Bcl2 (1:1000 sc-7382, Santa Cruz), FBXL5 (1:1000 
N0039, Neoclone Biotechnology) COX4I2 (1:1000 H00084701-M01 Abnova) and HO-1 
(1:1000 sc-1797, Santa Cruz).
Real-time qPCR
mRNA was extracted from lung tissue using the Qiagen RNA extraction kit (74104, Qiagen) 
and reverse transcribed with SuperScript III Reverse Tran- scriptase (Life Technologies). 
TaqMan primers for gene expression assays were purchased from Life Technologies. Real-
time qPCR was carried out with an ABI PRISM 7300 Sequence Detection System using 
TaqMan PCR Master Mix (Life Technologies). mRNA was extracted from cells using the 
Qiagen RNA extraction kit (74104, Qiagen) and reverse transcribed with SuperScript III 
Reverse Transcriptase (Life Technologies). mRNA in Supplementary Fig. 4f was used from 
RIP-Seq library preparations. TaqMan primers for human transferrin Receptor 1, human 
ferritin Heavy chain, human frataxin and human beta-actin for gene expression assays were 
purchased from Life Technologies. Real-time qPCR was carried out with an ABI PRISM 
7300 Sequence Detection System using TaqMan PCR Master Mix (Life Technologies).
Flow cytometry
To discriminate live and dead cells, cells were simultaneously stained with green fluorescent 
calcein-AM to indicate intracellular esterase activity and red fluorescent ethidium 
homodimer-1 to indicate loss of plasma membrane integrity using the LIVE/DEAD 
Viability/Cytotoxicity Kit (L-3224, Molecular Probes). mtROS was measured in cells by 
MitoSOX (M36008, Invitrogen) staining (2.5 μM for 10 minutes at 37 °C). Data were 
acquired with a FACSCanto II (BD Biosciences) and analyzed with FlowJo analytical 
software (Tree Star Inc.).
Confocal Imaging
80,000 Beas2B cells seeded onto poly-L-lysine coated cover slips in a 6 well plate were 
treated with CSE for the indicated times. The cells were permeabilized for 15 minutes in 
0.01% Triton-X 100 then washed in PBS twice and 0.5% bovine serum albumin (BSA) in 
PBS twice. The cells were blocked for 45 minutes with 2% BSA in PBS. The cells were 
washed once in 0.5% BSA and then incubated for 1 hour at room temperature with a 
primary rabbit IgG to human IRP2 (1:100, sc-33682, Santa Cruz). The samples were washed 
5 times with 0.5% BSA and then incubated for 1 hour at room temperature in secondary IgG 
Alexa 488 anti- rabbit (1:400). Nuclei were stained using DAPI.
Measurement of Fe-S cluster assembly in Beas2B cells
2Fe-S clusters were measured in Beas2B cells as previously described90. Briefly, 8 × 105 
Beas2B cells were transfected with constructs (0.8 μg) containing venus fluorescent protein 
fragments targeted to the mitochondrion or cytosol and conjugated to human glutaredoxin 2 
(GRX2) which coordinates 2Fe2S clusters for 24 h. Transfected cells were treated with 20% 
CSE for 0.5, 1 or 2 hours. The fluorescence of cells transiently transfected with vectors that 
express mitochondrial and cytosolic Venus-fragment pairs fused GRX2 was determined 
using flow cytometry (measuring FITC fluorescence). The fluorescence of Venus fragments 
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fused to the self-associating leucine zipper region of the yeast Gcn4 transcriptional activator 
were used as a control for Venus fragments that stably associate (data not shown).
Statistical analysis
Statistical analysis was conducted using GraphPad Prism software (GraphPad Software). 
Data are presented as the mean ± s.e.m. from at least two independent experiments. 
Differences in measured variables between experimental and control groups were assessed 
using the unpaired Student’s t test and between multiple groups and conditions using one-
way and two-way ANOVAs with subsequent Bonferroni-corrected pairwise tests. For MCC 
assays, a significant P value was followed by a pair-wise comparison using a two-sample t 
test for a priori hypotheses only. Thus, no adjustment in the significance level was made for 
multiple comparisons. Multi-variable regression was conducted using STATA/IC (v13) to 
isolate the effects of IRP2, C:P ratio, DFP, CS, and iron diets (Fig. 6a, c). P values were 
calculated and minimum statistical significance was accepted at P < 0.05. Mean values 
appeared to be normally distributed with each figure documenting an appropriate statistical 
test. For animals subjected to cigarette smoke exposure, early death was used as an 
exclusion criterion. However only one mouse died out of all the CS exposure studies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Irp2 is pathogenic in experimental COPD. (a) Irp2 protein (left), mRNA (right) (n = 8 per 
group), (b) representative (n = 4) EMSA (left) with quantification of total-Irp (n = 5 per 
group) and specific-Irp2 activity (n = 3 per group), (c) Irp1 protein expression (n = 3 per 
group) and (d) representative Irp2 immunostaining (arrows indicate Irp2) in WT mouse 
lungs exposed to room air (RA) or CS (1–6 months). (e) Representative Hematoxylin-Eosin 
stained lung-sections (left), (n= 3 mice per group) mean chord length (middle), weighted 
mean diameters (right) and (f) representative trichrome stained lung-sections (left) and ECM 
protein thickness around small airways (right) in WT and Irp2−/− mice exposed to RA or CS 
(6 months), staining; n = 2 technical replicates. (g) Cleaved caspase 3 (left) (ELISA, n = 7 
per group) and MMP-9 (right) (ELISA, WTRA n = 5; WTCS n = 3; Irp2−/− RA, CS n = 6) 
levels in whole lung of WT and Irp2−/− mice exposed to RA or CS (6 months), n = 2 
technical replicates. (h) 99mTc-SC clearance over 1–3 hours (left) in WT mouse lungs 
exposed to RA (n = 9) or CS (n = 10) (1 month). 3 hour 99mTc-SC clearance (right), (i) 
BALF IL-33 (left, ELISA; WTRA n = 3; WTCS n = 5; Irp2−/− RA n = 5; Irp2−/−C n = 6) 
and BALF IL-6 protein concentrations (right, ELISA, n = 3 per group) in WT and Irp2−/− 
mice exposed to RA or CS (1 month). (d–f) Scale bars, 50 μm. All data are mean ± s.e.m. *P 
< 0.05, **P < 0.01, ***P < 0.005 by one-way ANOVA with Bonferroni correction. #P < 
0.05, ##P < 0.01, ###P < 0.005 by student’s unpaired t-test. n.s., not significant.
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Figure 2. 
Novel targets of IRP2 in the lung. (a) Circos plot of communities of genes and GO terms to 
demonstrate gene transcripts and pathways enriched and/or altered in the RIP-Seq data set. 
CTL-specific (blue), DFO-specific (red) and common (purple) peak data sets are represented 
by individual rings, with the height of bars corresponding to the peak score (n = 2 biological 
replicates). Gene expression data (mRNA) from the LGRC (n = 121 COPD subjects, n = 20 
non-smokers and n = 18 smokers) represented on inner black ring. The height of these bars 
corresponds to the log2 fold-change (FC) in gene expression levels between subjects with 
COPD and controls. Green denotes lower expression in COPD and magenta denotes higher 
expression in COPD. Word Clouds representing GO terms in each community with the size 
of each word reflecting its frequency among the names of the pathways in the community. 
Community 1 shows enrichment for the cell cycle, metabolism of RNA, the proteasome and 
immune system; community 2 for metabolism, mitochondria and membrane trafficking; 
community 3 for DNA repair, apoptosis, the cell cycle and signal transduction; community 4 
for metabolism of proteins, transcription and translation; community 5 for nucleotide/purine 
metabolism pathways. (b) Functional enrichment clustering analysis workflow to evaluate 
collective differential expression of genes in “communities” of RIP-Seq and in Irp2−/− 
versus WT gene expression data. (c) Results of functional enrichment clustering analysis. 
***P = 1.08 x10−8 by a two-tailed unpaired t-test.
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Figure 3. 
Irp2−/− mice resist CS-induced mitochondrial dysfunction. (a) Community 2 genes that 
annotated to ‘mitochondria’ GO categories. Red text indicates mitochondrial OXPHOS 
genes. (b–c) Differential-expression of genes from (a) in the human COPD cohorts (b) 
LGRC (n = 121 COPD, n = 18 smokers and n = 20 non-smokers) and (c) ECLIPSE (n = 136 
COPD, n = 84 smokers, n = 6 non-smokers) related to low or high IRP2 expression. (d) 
Representative TEM images (n=20 images per mouse) (left) and quantification (right) of 
WT or Irp2−/− mouse airways exposed to RA or CS (4 months)(15 EM fields, n = 1 per 
group). Scale bar: 500 nm. Arrows indicate ‘abnormal’ mitochondria. n; nuclei; m; 
mitochondria. (e) Representative cytochrome c immunostaining (n=3 mice per group) 
(arrows indicate staining, scale bar, 50 μm) and (f) percentage JC1 uptake (mitochondrial-
enriched fractions, n = 3 technical replicates) of WT or Irp2−/− mouse lungs exposed to RA 
or CS (4 (e) or 6 months (f)). (g) Representative TMRE staining (n=3 experiments) (bottom) 
(n = 2 technical replicates) with fold change mean fluorescent intensity (top) of TMRE, (h) 
OCR (left) and ECAR (right) normalized to Hoechst (n = 12 technical replicates) of WT and 
Irp2−/− primary lung epithelial cells treated with 20% CSE (4 hours) or FCCP (30 mins). (i) 
Schematic of the role of IRP2 in mitochondrial responses to CS. All data are mean ± 
s.e.m.: #P < 0.05. ##P < 0.01 by student’s unpaired t-test. *P < 0.05, **P < 0.01 by one-way 
ANOVA with Bonferroni correction.
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Figure 4. 
IRP2-associated mitochondrial iron loading and CS. (a) Representative Perls’ stained lung 
sections (n=3 mice per group) (left) (n = 2 technical replicates) with quantification (middle) 
(n = 10 images per mouse, n = 3 per group) and non-heme iron levels (right, n = 4 mice per 
group, n = 4 technical replicates) in WT mice exposed to RA or CS (1–6 months). Scale 
bars, 50 μm. Arrows indicate staining. n.c.; negative control. (b) Representative immunoblot 
(n=3 experiments) (left) with quantification (right) of transferrin and ferritin expression (n = 
5 per group, n = 2 technical replicates), (c) total non-heme iron (left, n = 5 mice per group, n 
= 4 technical replicates) and fold change mitochondrial (RA n = 11; CS 1 month n = 6, 4 
months n = 8, 6 months n = 9) and cytosolic non-heme (RA n = 6; CS 1 month n = 11, 4 
months n = 3, 6 months n = 5) iron (right) in WT mouse lungs exposed to RA or CS, n = 2 
technical replicates. (d) Fold change non-heme iron (left, WT and Irp2−/−; RA n = 13, CS 1 
and 6 months n =5, CS 4 months n =3) and heme-iron (right, WT and Irp2−/−; RA n = 10, 
CS 1–6 months n =5) in mitochondrial fractions from WT mouse lungs exposed to RA or 
CS, n = 2 technical replicates. (e) Mitoferrin 2 (WT and Irp2−/−; RA n = 8; CS 1 month n = 
3, 4 months n = 6), (f) frataxin expression (WT RA n = 5; CS n = 3; Irp2−/− RA n = 6; CS n 
= 6) in whole lung of mice exposed to RA or CS. (g) Mitochondrial non-heme (left, n = 4 
per group), mitochondrial heme iron (right, n = 4 per group), (h) 3 hour 99mTc-SC clearance 
(left) and IL-6 protein concentrations (right, n = 4 per group) in the lungs of WT and 
Fxnki/ko mice exposed to RA or CS (1 month). (i) Schematic of mitochondrial iron loading 
regulated by Irp2. All data are mean ± s.e.m. *P < 0.05. **P < 0.01, ***P < 0.005 by one-
way ANOVA followed by Bonferroni correction. #P < 0.05 by student’s unpaired t-test.
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Figure 5. 
COX is pathogenic in experimental COPD. (a) Coa3 expression (left) in WT (n = 6) and 
Irp2−/− (n = 5) mouse lungs, schematic of COX assembly (middle) and COX expression by 
immunoblot analysis (right) in lung tissue from individuals with COPD (n = 5) and controls 
(n = 5), n = 2 technical replicates. (b) Representative immunoblot (n=3 experiments) 
expression (left) of OXPHOS complexes I-V in mitochondrial-enriched fractions from WT 
and Irp2−/− mouse lungs exposed to RA or CS (4 months), with quantification of Complex 
IV expression (right), n = 3 technical replicates. (c) Time course of COX activity (left) and 
total COX activity (4 months CS) in mitochondrial fractions of WT or Irp2−/− mice exposed 
to RA or CS (n = 3 per group, n = 3 technical replicates). (d) Representative immunoblot 
(n=3 experiments) (left) as in (b), time course of COX activity (middle) and COX activity at 
4 hours (right) in primary lung epithelial cells from WT or Irp2−/− mice exposed to 20% 
CSE, n = 2 per group, n = 2 technical replicates. (e) 3 hour 99mTc-SC clearance (left), total 
BALF leukocytes (middle), total protein levels (right), (f) BALF IL-33 (left, ELISA; WT 
RA n = 4; CS n = 5; Sco2ki/ko RA n = 5, CS n = 4), BALF IL-6 (right, ELISA; WT RA n = 
4; CS n = 5; Sco2ki/ko RA n = 5, CS n = 4),) protein concentration, (g) total lung non-heme 
iron (n = 4 per group), (h) mitochondrial non-heme iron (left, n = 3 per group) and 
mitochondrial-heme iron (right, n =3 per group) levels in WT and Sco2ki/ko mice exposed to 
RA or CS (1 month), (f, g) n = 3 technical replicates. (i) Schematic of the role of COX Irp2-
associated mitochondrial iron loading. All data are mean ± s.e.m. *P < 0.05. **P < 0.01, 
***P < 0.005 by one-way ANOVA followed by Bonferroni correction. #P < 0.05, ##P < 
0.01, ###P < 0.005 by unpaired student’s t-test.
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Figure 6. 
Targeting mitochondrial iron in experimental COPD. (a) 3 hour 99mTc-SC clearance and (b) 
percentage weight gain of WT mice exposed to RA or CS (1 month) on a control (300 ppm 
iron), low iron (6 ppm iron) or high iron (2% carbonyl iron) diet. (c) 3 hour 99mTc-SC 
clearance in WT and Irp2−/− mice exposed to RA or CS (1 month) and treated with DFP as 
a prophylactic dosing strategy or as a therapeutic dosing strategy; blue arrows indicate point 
of DFP addition. (d) Percentage weight gain (relative to initial weight at the start of smoke 
exposure) (4 weeks CS n = 17; 5 weeks CS n = 12; 6 weeks CS n = 12; 7 weeks CS n = 4; 8 
weeks CS n = 4; 4 weeks + DFP n = 11; 5 weeks + DFP n = 11; 6 weeks + DFP n = 11; 7 
weeks + DFP n = 5; 8 weeks + DFP n = 4), (e) fold change in lung mitochondrial non-heme 
iron (control n = 8;DFP control n = 8; 1 month CS n = 10; 6 weeks CS n = 4; 6 weeks +DFP 
n = 4; 8 weeks CS n = 4; 8 weeks CS +DFP n = 4; n = 2 technical replicates), (f) total BAL 
leukocytes and (g) total BALF protein in WT mice treated with DFP using a therapeutic 
dosing strategy as in (c), but continued for 2 or 4 weeks of CS exposures. Black arrows 
indicate time of CS exposure and blue arrows indicate time of DFP addition. (h) Schematic 
of the major findings of this study. All data are mean ± s.e.m. *P < 0.05. **P < 0.01, ***P < 
0.005 by one-way ANOVA followed by Bonferroni correction.
Cloonan et al. Page 37
Nat Med. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
